Vital Signs (VITL) Beats Q2 View By A Penny

August 7, 2008 4:31 PM EDT

Vital Signs (Nasdaq: VITL) reports Q2 EPS of $0.73, 1 cent better than the analyst estimate of $0.72. Revenues for the quarter were $60.6 million, versus the consensus of $59.04 million.


Related Categories

Earnings

Stocks Mentioned

VITL 74.46

+0.00 +0.00%
Volume: 415,299
Track VITL


Add Your Comment